Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · March 21, 2018

Frequency and Level of Evidence Used in Recommendations by the NCCN Guidelines Beyond Approvals of the FDA

BMJ: British Medical Journal

 

Additional Info

Disclosure statements are available on the authors' profiles:

BMJ: British Medical Journal
Frequency and Level of Evidence Used in Recommendations by the National Comprehensive Cancer Network Guidelines Beyond Approvals of the US Food and Drug Administration: Retrospective Observational Study
BMJ 2018 Mar 07;360(xx)k668, J Wagner, J Marquart, J Ruby, A Lammers, S Mailankody, V Kaestner, V Prasad

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading